Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.5 USD | +0.81% | -3.05% | +15.15% |
31/05 | Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival | RE |
31/05 | Sector Update: Health Care | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.15% | 32TCr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Insider Sold Shares Worth $4,805,521, According to a Recent SEC Filing